NZX-listed medical cannabis companies Rua Bioscience and Cannsouth are continuing to post hefty losses ahead of launching products into the market, but both assured shareholders it was all part of their plan.
Rua posted a loss of $4.42 million for the year ended June 30 and Cannasouth posted a
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).
